ZTS - Zoetis Inc.
122.23
-3.730 -3.052%
Share volume: 4,088,022
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$125.96
-3.73
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-06-2024 | 11-04-2024 | 02-13-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 14.348 B | 14.165 B | 14.357 B | 14.237 B | 14.098 B | 14.479 B | 15.159 B | 15.467 B | |
| Current Assets | 6.359 B | 6.202 B | 6.282 B | 5.986 B | 5.877 B | 5.923 B | 6.583 B | 6.768 B | |
| Inventories | 2.651 B | 2.452 B | 2.416 B | 2.306 B | 2.365 B | 2.439 B | 2.465 B | 2.430 B | |
| Other Current Assets | 440.000 M | 467.000 M | 427.000 M | 377.000 M | 430.000 M | 509.000 M | 493.000 M | 436.000 M | |
| Short Term Investments | 440.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 1.293 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.975 B | 1.574 B | 1.714 B | 1.987 B | 1.721 B | 1.435 B | 2.084 B | 2.312 B | |
| Total Non-current Assets | 7.989 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.251 B | 3.200 B | 3.298 B | 3.391 B | 3.441 B | 3.537 B | 3.600 B | 3.681 B | |
| Other Assets | 227.000 M | 4.763 B | 4.777 B | 4.860 B | 4.780 B | 5.019 B | 4.976 B | 5.018 B | |
| Intangible Assets | 1.295 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 2.759 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 14.348 B | 14.165 B | 14.357 B | 14.237 B | 14.098 B | 14.479 B | 15.159 B | 15.467 B | |
| Total liabilities | 9.290 B | 9.205 B | 9.123 B | 9.467 B | 9.443 B | 9.502 B | 9.761 B | 12.136 B | |
| Total current liabilities | 1.909 B | 1.797 B | 1.702 B | 3.412 B | 3.385 B | 3.366 B | 1.807 B | 2.235 B | |
| Accounts Payable | 405.000 M | 420.000 M | 404.000 M | 433.000 M | 420.000 M | 508.000 M | 410.000 M | 487.000 M | |
| Other liabilities | 505.000 M | 403.000 M | 401.000 M | 396.000 M | 393.000 M | 484.000 M | 468.000 M | 444.000 M | |
| Current long term debt | 24.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.562 B | 6.563 B | 6.574 B | 5.220 B | 5.227 B | 5.231 B | 7.069 B | 9.042 B | |
| Other liabilities | 505.000 M | 403.000 M | 401.000 M | 396.000 M | 393.000 M | 484.000 M | 468.000 M | 444.000 M | |
| Minority interest | -6.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.058 B | 4.966 B | 5.234 B | 4.770 B | 4.655 B | 4.977 B | 5.398 B | 3.331 B | |
| Common stock | 458.000 M | 1.151 B | 1.168 B | 1.187 B | 1.185 B | 1.208 B | 1.229 B | 1.106 B | |
| Retained earnings | 10.696 B | 11.124 B | 11.806 B | 11.968 B | 12.375 B | 12.872 B | 13.593 B | 13.744 B |